Abiopharma

🔍 Page Russell Andrew (Executive)

Company: Hagerty, Inc. (HGTY)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 30,865 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 142,889.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,146 shares of Class A Common Stock at $10.66 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 131,743.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares of Class A Common Stock of Hagerty, Inc. ("Class A Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person under the Hagerty, Inc. (the "Issuer") 2021 Equity Incentive Plan (the "Plan"). The RSUs vest in equal amounts on each annual-anniversary of the grant date ending on April 1, 2029, subject to the Reporting Person's continued service with the Issuer, with exceptions for death, disability, or retirement terminations, or a change of control of the Issuer.
• F2: Represents total number of shares of Class A Common Stock of the Issuer withheld for taxes upon vesting of RSUs pursuant to various RSU award agreements.